Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;131(1):17006.
doi: 10.1289/EHP11089. Epub 2023 Jan 25.

Soy-Based Infant Formula Feeding and Uterine Fibroid Development in a Prospective Ultrasound Study of Black/African-American Women

Affiliations

Soy-Based Infant Formula Feeding and Uterine Fibroid Development in a Prospective Ultrasound Study of Black/African-American Women

Christine R Langton et al. Environ Health Perspect. 2023 Jan.

Abstract

Background: Uterine fibroids are highly prevalent, benign tumors. They are the leading indication for hysterectomy, and Black women are disproportionally burdened. Soy-based infant formula contains phytoestrogens, and exposure during sensitive developmental windows may adversely affect the developing uterus; early phytoestrogen treatment in rodent studies led to detrimental uterine effects, including increased fibroid risk in Eker rats. Limited epidemiological studies also have suggested increased fibroid development with soy formula infant feeding.

Objective: The goal of this study was to examine the association between soy formula feeding in infancy and fibroid development in adulthood.

Methods: We evaluated this association among 1,610 Black/African-American women age 23-35 y in the Study of Environment, Lifestyle & Fibroids (SELF). Soy formula feeding data was gathered directly from the participants' mothers (89%). A standardized ultrasound examination was conducted during 4 clinic visits over 5 y to detect fibroids 0.5cm in diameter. We used Cox proportional hazards regression to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between soy formula feeding and incident fibroids adjusted for early-life and adult factors. Fibroid growth was calculated as change in log-volume for fibroids matched at successive visits.

Results: Of 1,121 fibroid-free participants at baseline, 150 (13%) were ever fed soy formula as infants, and 269 (24%) developed incident fibroids. We did not observe an association between ever being fed soy formula and incident fibroid risk (HR=1.08; 95% CI: 0.75, 1.54). However, participants fed soy formula within 2 months of birth and for >6 months (n=53) had an elevated risk of fibroid incidence in comparison with those never fed soy formula (HR=1.56; 95% CI: 0.92, 2.65). Fibroid growth rates did not differ.

Discussion: Adding support to limited human data, this prospective fibroid study found that soy-based formula feeding during infancy was associated with a suggestive increase in risk of ultrasound-identified incident fibroids in adulthood. https://doi.org/10.1289/EHP11089.

PubMed Disclaimer

Figures

Figure 1 is a flowchart with four steps. Step 1: There were 1610 participants with follow-up data. Of these, the following participants were excluded: 364 participants who had fibroids detected at enrollment, 5 participants who had a nonfibroid-related hysterectomy before their first visit, and 9 participants who had ultrasound quality issues. Step 2: There were 1232 participants who were eligible for incidence analysis. Of these, the following were excluded due to missing soy formula data: 34 participants who did not return the early-life questionnaire, 27 participants who responded "don't know" to soy formula questions, and 6 participants who skipped the soy formula question. Step 3: There were 1165 participants who were eligible with soy formula data. Of these, 44 participants had missing covariate data and were excluded for the following reasons: 1 for missing maternal education, 8 for missing mother's age at birth, 11 for missing maternal diabetes or G D M, and 15 for missing maternal HDP. Step 4: There were 1121 participants in the analytical sample.
Figure 1.
Flowchart of participant selection for incidence analysis, Study of Environment, Lifestyle & Fibroids (SELF), 2010–2018. Of the 1,610 participants at baseline with follow-up data available, a total of 1,121 were included in the analytical sample for incident fibroids (n=269).

Similar articles

Cited by

References

    1. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. 2003. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188(1):100–107, PMID: , 10.1067/mob.2003.99. - DOI - PubMed
    1. Wise LA, Laughlin-Tommaso SK. 2016. Epidemiology of uterine fibroids: from menarche to menopause. Clin Obstet Gynecol 59(1):2–24, PMID: , 10.1097/GRF.0000000000000164. - DOI - PMC - PubMed
    1. Giuliani E, As-Sanie S, Marsh EE. 2020. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet 149(1):3–9, PMID: , 10.1002/ijgo.13102. - DOI - PubMed
    1. Laughlin SK, Schroeder JC, Baird DD. 2010. New directions in the epidemiology of uterine fibroids. Semin Reprod Med 28(3):204–217, PMID: , 10.1055/s-0030-1251477. - DOI - PMC - PubMed
    1. Catherino WH, Eltoukhi HM, Al-Hendy A. 2013. Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma. Semin Reprod Med 31(5):370–379, PMID: , 10.1055/s-0033-1348896. - DOI - PMC - PubMed

Publication types